Organigram Global Inc. (OGI) Comparison with companies in other sectors?

Organigram Global Inc. has a share price of 133.88M. You can analyze Organigram Global Inc. (OGI) competitors across different market sectors through stock heatmaps.

What are OGI's NET and operating margins?

Organigram Global Inc. (OGI) operating margin is around -0.12, and net profit margin is approximately 0.09 as of the latest reports.

In what way does OGI's earnings per share (EPS) trend reflect its financial momentum?

Organigram Global Inc. (OGI) EPS is 0.13 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Organigram Global Inc. is 11.77, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Organigram Global Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Organigram Global Inc. like P/E which is 15.77, P/B which is 0.68, and PEG which is 0.10. Compare them with sector averages to evaluate if the stock is priced fairly.

Organigram Global Inc.

OGI•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$1.53

$0.02(1.32%)

Fundamental Analysis of Organigram Global Inc. (OGI)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.13

P/E Ratio

11.77

ROE

0.05%

Net Margin

0.09%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$204.84M

Shares OutstandingTotal number of shares issued

$133.88M

Book Value/ShareNet worth per share

$3.03

Revenue/ShareAnnual revenue per share

$1.50

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.13

Net MarginNet income as percentage of revenue

8.70%

Operating MarginOperating income as percentage of revenue

-12.19%

ROEReturn on shareholders' equity

5.13%

ROAReturn on total assets

3.14%

ROCEReturn on capital employed

-5.12%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.21

Cash/ShareCash and equivalents per share

$0.11

FCF YieldFree cash flow as percentage of market cap

-9.62%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for OGIFinancial Ratios Analysis details for OGI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for OGISector Benchmarking details for OGI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Organigram Global Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Organigram Global Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Organigram Global Inc.'s unique business strengths and challenges.

Key Financial Metrics for Organigram Global Inc.

For Organigram Global Inc., essential financial indicators include EPS 0.13, PE 11.77, and ROE 0.05. These key ratios reveal insights into Organigram Global Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Organigram Global Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Organigram Global Inc.

Metrics like Net Margin 8.70% and ROA 3.14% shed light on how well Organigram Global Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Organigram Global Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Organigram Global Inc.

Using ratios such as P/B Ratio 0.68 and PEG Ratio 0.10, investors can assess whether Organigram Global Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Organigram Global Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Organigram Global Inc.

Financial health indicators, such as Debt/Equity Ratio 0.02 and Cash Flow $-0.21, provide a snapshot of Organigram Global Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Organigram Global Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Organigram Global Inc.

Investing in Organigram Global Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Organigram Global Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;